Judge reluctantly allows a third insider trading trial

A federal judge allowed a rare third trial for an ophthalmology executive accused of insider trading, though he questioned why he doesn’t have the authority to enter a not guilty verdict after the last jury hung overwhelmingly in favor of acquittal.

SANTA ANA -- A federal judge on Tuesday allowed a rare third trial for an ophthalmology executive accused of insider trading, though he questioned why he doesn't have the authority to enter a not guilty verdict after the last jury hung overwhelmingly in favor of acquittal.

U.S. District Judge Andrew J. Guilford said the U.S. attorney's office is "apparently ignoring two previous juries' conclusions about the merits of the case" again...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?
Sign In

Filter by date

Exact Phrase

Not the words

At least one of the words

All the words

Securities, Civil Litigation, Criminal, Administrative/Regulatory

May 2, 2018

Judge reluctantly allows a third insider trading trial

Related Content

Securities, Civil Litigation, Criminal

Civil Litigation, Government, Criminal

Securities, Criminal, Corporate

Securities, Criminal

Securities, Criminal, Corporate

Securities, Government, Entertainment & Sports, Criminal

Criminal

Law Practice, Criminal

Criminal

Criminal

Criminal

Criminal

Criminal

Criminal

Securities,

Civil Litigation,

Criminal,

Administrative/Regulatory